View in EDS HTML Full Text PDF Full Text

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.

Saved in:
Bibliographic Details
Title: CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
Authors: Alves WEFM; Nuclear Medicine and Molecular Imaging Department, Barretos Cancer Hospital - Pio XII Foundation, Rua Antenor Duarte Vilela, N° 1331, Barretos, São Paulo, 14784-400, Brazil. wefma@yahoo.com.br.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil. wefma@yahoo.com.br., Bonatelli M; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Dufloth R; Pathology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Kerr LM; Pathology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Carrara GFA; Surgery Department, Federal University of Triangulo Mineiro, Uberaba, Minas Gerais, Brazil., da Costa RFA; Research and Teaching Institute, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos, São Paulo, Brazil., Scapulatempo-Neto C; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Tiezzi D; Department of Gynecology and Obstetrics - Breast Disease Division, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribreirão Preto, São Paulo, Brazil., da Costa Vieira RA; Department of Mastology and Breast Reconstruction, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Pinheiro C; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos, São Paulo, Brazil.
Source: BMC cancer [BMC Cancer] 2019 Dec 03; Vol. 19 (1), pp. 1173. Date of Electronic Publication: 2019 Dec 03.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31795962
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Alves+WEFM%22">Alves WEFM</searchLink>; Nuclear Medicine and Molecular Imaging Department, Barretos Cancer Hospital - Pio XII Foundation, Rua Antenor Duarte Vilela, N° 1331, Barretos, São Paulo, 14784-400, Brazil. wefma@yahoo.com.br.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil. wefma@yahoo.com.br.<br /><searchLink fieldCode="AU" term="%22Bonatelli+M%22">Bonatelli M</searchLink>; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Dufloth+R%22">Dufloth R</searchLink>; Pathology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Kerr+LM%22">Kerr LM</searchLink>; Pathology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Carrara+GFA%22">Carrara GFA</searchLink>; Surgery Department, Federal University of Triangulo Mineiro, Uberaba, Minas Gerais, Brazil.<br /><searchLink fieldCode="AU" term="%22da+Costa+RFA%22">da Costa RFA</searchLink>; Research and Teaching Institute, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Scapulatempo-Neto+C%22">Scapulatempo-Neto C</searchLink>; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Tiezzi+D%22">Tiezzi D</searchLink>; Department of Gynecology and Obstetrics - Breast Disease Division, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribreirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22da+Costa+Vieira+RA%22">da Costa Vieira RA</searchLink>; Department of Mastology and Breast Reconstruction, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Pinheiro+C%22">Pinheiro C</searchLink>; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos, São Paulo, Brazil.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2019 Dec 03; Vol. 19 (1), pp. 1173. <i>Date of Electronic Publication: </i>2019 Dec 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31795962
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-019-6353-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1173
    Titles:
      – TitleFull: CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alves WEFM
      – PersonEntity:
          Name:
            NameFull: Bonatelli M
      – PersonEntity:
          Name:
            NameFull: Dufloth R
      – PersonEntity:
          Name:
            NameFull: Kerr LM
      – PersonEntity:
          Name:
            NameFull: Carrara GFA
      – PersonEntity:
          Name:
            NameFull: da Costa RFA
      – PersonEntity:
          Name:
            NameFull: Scapulatempo-Neto C
      – PersonEntity:
          Name:
            NameFull: Tiezzi D
      – PersonEntity:
          Name:
            NameFull: da Costa Vieira RA
      – PersonEntity:
          Name:
            NameFull: Pinheiro C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 12
              Text: 2019 Dec 03
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1